us-gaap:SeriesCPreferredStockMember\\n \\n \\n \\n 2024-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n gpox:FounderSeriesANonVotingRedeemablePreferredStockMember \\n \\n \\n \\n 2024-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n gpox:FounderSeriesANonVotingRedeemablePreferredStockMember \\n \\n \\n \\n 2023-04-30 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n gpox:SeriesAPreferredStocksMember \\n \\n \\n \\n 2022-04-30 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n gpox:SeriesANonVotingRedeemablePreferredStockMember \\n \\n \\n \\n 2023-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n gpox:SeriesANonVotingRedeemablePreferredStockMember \\n \\n \\n \\n 2021-04-30 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n gpox:SeriesAPreferredStocksMember \\n \\n \\n \\n 2024-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n gpox:SeriesAPreferredStocksMember \\n \\n \\n \\n 2023-04-30 \\n \\n \\n\\t\\n iso4217:USD \\n \\n\\t\\n shares \\n \\n\\t\\n \\n \\n iso4217:USD \\n \\n \\n shares \\n \\n \\n \\n\\t\\n pure \\n \\n\\t1399842 \\n\\t517037 \\n\\t32470 \\n\\t43614 \\n\\t32470 \\n\\t43614 \\n\\t346003 \\n\\t0 \\n\\t39454300 \\n\\t44108860 \\n\\t115000 \\n\\t5000000 \\n\\t2440863 \\n\\t0 \\n\\t115000 \\n\\t115000 \\n\\t2440863 \\n\\t637083 \\n\\t1803780 \\n\\t916415 \\n\\t406662 \\n\\t55496 \\n\\t8844 \\n\\t69351 \\n\\t8844 \\n\\t69351 \\n\\t1361368 \\n\\t514337 \\n\\t Concentration Risk Type [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/SegmentReporting\\n Path: Concentration Risk Type [Axis] > Concentration Risk Type [Domain]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/FinancialServicesInsurance\\n Path: Ceded Credit Risk [Table] > Concentration Risk Type [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/FinancialServicesInsurance\\n Path: Concentration Risk Type [Axis] > Concentration Risk Type [Domain]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatements\\n Path: Nature of Operation, Product Information, Concentration of Risk [Table] > Concentration Risk Type [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatements\\n Path: Concentration Risk Type [Axis] > Concentration Risk Type [Domain]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthers\\n Path: Accounts and Financing Receivables [Table] > Concentration Risk Type [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthers\\n Path: Concentration Risk Type [Axis] > Concentration Risk Type [Domain]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/AccountingPolicies\\n Path: Nature of Operation, Product Information, Concentration of Risk [Table] > Concentration Risk Type [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/AccountingPolicies\\n Path: Concentration Risk Type [Axis] > Concentration Risk Type [Domain]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/RisksAndUncertainties\\n Path: Concentration Risk [Table] > Concentration Risk Type [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/RisksAndUncertainties\\n Path: Concentration Risk Type [Axis] > Concentration Risk Type [Domain]\\n PreferredLabel: None\\nProvenance: sheets include Presentation-like sheets\\n\\n\\n[Concept Relations]\\nID: us-gaap:ConcentrationRiskByTypeAxis\\n\\nDefinition (Dimensions/Domain/Hypercube):\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTable -> to=us-gaap:ConcentrationRiskByTypeAxis (role=http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthersScheduleOfAccountsNotesLoansAndFinancingReceivableTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthersScheduleOfAccountsNotesLoansAndFinancingReceivableTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthersScheduleOfAccountsNotesLoansAndFinancingReceivableTable)\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable -> to=us-gaap:ConcentrationRiskByTypeAxis (role=http://fasb.org/us-gaap/role/disclosure/SegmentReportingScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/SegmentReportingScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/SegmentReportingScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable)\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:ScheduleOfProductInformationTable -> to=us-gaap:ConcentrationRiskByTypeAxis (role=http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatementsScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatementsScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatementsScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:ScheduleOfProductInformationTable -> to=us-gaap:ConcentrationRiskByTypeAxis (role=http://fasb.org/us-gaap/role/disclosure/AccountingPoliciesScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/AccountingPoliciesScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/AccountingPoliciesScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:ConcentrationRiskTable -> to=us-gaap:ConcentrationRiskByTypeAxis (role=http://fasb.org/us-gaap/role/disclosure/RisksAndUncertaintiesConcentrationRiskTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/RisksAndUncertaintiesConcentrationRiskTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/RisksAndUncertaintiesConcentrationRiskTable)\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:CededCreditRiskTable -> to=us-gaap:ConcentrationRiskByTypeAxis (role=http://fasb.org/us-gaap/role/disclosure/FinancialServicesInsuranceCededCreditRiskTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/FinancialServicesInsuranceCededCreditRiskTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/FinancialServicesInsuranceCededCreditRiskTable)\\nProvenance: sheets include Definition-like sheets\\n\\n\\n[Concept Relations]\\nID: us-gaap:ConcentrationRiskByTypeAxis\\n\\nReferences:\\n- Taxonomy Implementation Guide | None | None\\nProvenance: sheets include Reference-like sheets\\n\\n\\n[Concept Relations]\\nID: us-gaap:ConcentrationRiskByBenchmarkAxis\\n\\nPresentation:\\n- Role: http://fasb.org/us-gaap/role/disclosure/SegmentReporting\\n Path: Schedule of Revenue by Major Customers, by Reporting Segments [Table] > Concentration Risk Benchmark [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/SegmentReporting\\n Path: Concentration Risk Benchmark [Axis] > Concentration Risk Benchmark [Domain]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/FinancialServicesInsurance\\n Path: Ceded Credit Risk [Table] > Concentration Risk Benchmark [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/FinancialServicesInsurance\\n Path: Concentration Risk Benchmark [Axis] > Concentration Risk Benchmark [Domain]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatements\\n Path: Nature of Operation, Product Information, Concentration of Risk [Table] > Concentration Risk Benchmark [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatements\\n Path: Concentration Risk Benchmark [Axis] > Concentration Risk Benchmark [Domain]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthers\\n Path: Accounts and Financing Receivables [Table] > Concentration Risk Benchmark [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthers\\n Path: Concentration Risk Benchmark [Axis] > Concentration Risk Benchmark [Domain]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/AccountingPolicies\\n Path: Nature of Operation, Product Information, Concentration of Risk [Table] > Concentration Risk Benchmark [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/AccountingPolicies\\n Path: Concentration Risk Benchmark [Axis] > Concentration Risk Benchmark [Domain]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/RisksAndUncertainties\\n Path: Concentration Risk [Table] > Concentration Risk Benchmark [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/RisksAndUncertainties\\n Path: Concentration Risk Benchmark [Axis] > Concentration Risk Benchmark [Domain]\\n PreferredLabel: None\\nProvenance: sheets include Presentation-like sheets\\n\\n\\n[Concept Relations]\\nID: us-gaap:ConcentrationRiskByBenchmarkAxis\\n\\nDefinition (Dimensions/Domain/Hypercube):\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTable -> to=us-gaap:ConcentrationRiskByBenchmarkAxis (role=http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthersScheduleOfAccountsNotesLoansAndFinancingReceivableTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthersScheduleOfAccountsNotesLoansAndFinancingReceivableTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthersScheduleOfAccountsNotesLoansAndFinancingReceivableTable)\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable -> to=us-gaap:ConcentrationRiskByBenchmarkAxis (role=http://fasb.org/us-gaap/role/disclosure/SegmentReportingScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/SegmentReportingScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/SegmentReportingScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable)\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:ScheduleOfProductInformationTable -> to=us-gaap:ConcentrationRiskByBenchmarkAxis (role=http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatementsScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatementsScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatementsScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:ScheduleOfProductInformationTable -> to=us-gaap:ConcentrationRiskByBenchmarkAxis (role=http://fasb.org/us-gaap/role/disclosure/AccountingPoliciesScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/AccountingPoliciesScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/AccountingPoliciesScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:ConcentrationRiskTable -> to=us-gaap:ConcentrationRiskByBenchmarkAxis (role=http://fasb.org/us-gaap/role/disclosure/RisksAndUncertaintiesConcentrationRiskTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/RisksAndUncertaintiesConcentrationRiskTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/RisksAndUncertaintiesConcentrationRiskTable)\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:CededCreditRiskTable -> to=us-gaap:ConcentrationRiskByBenchmarkAxis (role=http://fasb.org/us-gaap/role/disclosure/FinancialServicesInsuranceCededCreditRiskTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/FinancialServicesInsuranceCededCreditRiskTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/FinancialServicesInsuranceCededCreditRiskTable)\\nProvenance: sheets include Definition-like sheets\\n\\n\\n[Concept Relations]\\nID: us-gaap:ConcentrationRiskByBenchmarkAxis\\n\\nReferences:\\n- Taxonomy Implementation Guide | None | None\\nProvenance: sheets include Reference-like sheets\\n\\n\\n[Concept Relations]\\nID: us-gaap:AccountsReceivableMember\\n\\nPresentation:\\n- Role: http://fasb.org/us-gaap/role/disclosure/SegmentReporting\\n Path: Concentration Risk Benchmark [Domain] > Accounts Receivable [Member]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthers\\n Path: Concentration Risk Benchmark [Domain] > Accounts Receivable [Member]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/FinancialInstrumentsFairValueDisclosures\\n Path: Asset Class [Domain] > Accounts Receivable [Member]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/RisksAndUncertainties\\n Path: Concentration Risk Benchmark [Domain] > Accounts Receivable [Member]\\n PreferredLabel: None\\nProvenance: sheets include Presentation-like sheets\\n\\n\\n[Concept Relations]\\nID: us-gaap:AccountsReceivableMember\\n\\nDefinition (Dimensions/Domain/Hypercube):\\n- http://xbrl.org/int/dim/arcrole/domain-member: from=us-gaap:ConcentrationRiskBenchmarkDomain -> to=us-gaap:AccountsReceivableMember (role=http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthersScheduleOfAccountsNotesLoansAndFinancingReceivableTable)\\n- http://xbrl.org/int/dim/arcrole/domain-member: from=us-gaap:ConcentrationRiskBenchmarkDomain -> to=us-gaap:AccountsReceivableMember (role=http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthersScheduleOfAccountsNotesLoansAndFinancingReceivableTable)\\n- http://xbrl.org/int/dim/arcrole/domain-member: from=us-gaap:ConcentrationRiskBenchmarkDomain -> to=us-gaap:AccountsReceivableMember (role=http://fasb.org/us-gaap/role/disclosure/SegmentReportingScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable)\\n- http://xbrl.org/int/dim/arcrole/domain-member: from=us-gaap:ConcentrationRiskBenchmarkDomain -> to=us-gaap:AccountsReceivableMember (role=http://fasb.org/us-gaap/role/disclosure/SegmentReportingScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable)\\n- http://xbrl.org/int/dim/arcrole/domain-member: from=us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain -> to=us-gaap:AccountsReceivableMember (role=http://fasb.org/us-gaap/role/disclosure/FinancialInstrumentsFairValueDisclosuresFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable)\\n- http://xbrl.org/int/dim/arcrole/domain-member: from=us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain -> to=us-gaap:AccountsReceivableMember (role=http://fasb.org/us-gaap/role/disclosure/FinancialInstrumentsFairValueDisclosuresFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable)\\n- http://xbrl.org/int/dim/arcrole/domain-member: from=us-gaap:ConcentrationRiskBenchmarkDomain -> to=us-gaap:AccountsReceivableMember (role=http://fasb.org/us-gaap/role/disclosure/RisksAndUncertaintiesConcentrationRiskTable)\\n- http://xbrl.org/int/dim/arcrole/domain-member: from=us-gaap:ConcentrationRiskBenchmarkDomain -> to=us-gaap:AccountsReceivableMember (role=http://fasb.org/us-gaap/role/disclosure/RisksAndUncertaintiesConcentrationRiskTable)\\nProvenance: sheets include Definition-like sheets\\n\\nQuestion: Which axis-member pairs in the instance document report the concept \\\"ConcentrationRiskPercentage1\\\" with both \\\"ConcentrationRiskByTypeAxis\\\" and \\\"ConcentrationRiskByBenchmarkAxis\\\" but without any third axis, excluding cases where the member is \\\"LaborForceConcentrationRiskMember\\\" or \\\"UnionizedEmployeesConcentrationRiskMember\\\"?\\nAnswer:\\n\\n\""},"dqc_id":{"kind":"string","value":"\"DQC_US_0109\""},"answer":{"kind":"string","value":"\"['us-gaap:ConcentrationRiskByTypeAxis=gpox:TwoCustomerConcentrationRiskMember', 'us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:AccountsReceivableMember']\""},"id":{"kind":"number","value":180,"string":"180"}}},{"rowIdx":181,"cells":{"query":{"kind":"string","value":"\"You are an auditor for XBRL filings. Given the question and the provided filing \\n(schema, presentation, calculation, definition, label, instance, and US GAAP taxonomy), \\nidentify erroneous US-GAAP concepts.\\n\\nYou must reference the US GAAP taxonomy to retrieve and check elements across the entire filing. \\nOutput only a JSON array of strings, each string is one erroneous concept.\\nOutput Example:\\n[\\\"us-gaap:Revenues\\\", \\\"us-gaap:OperatingIncomeLoss\\\"]\\n\\nNo explanations. No extra text. Only the JSON array.\\n\\n\\n##Schema document\\n\\n\\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n 000035 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) \\n link:presentationLink \\n link:calculationLink \\n link:definitionLink \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n Merchandise And Product Sales [Member] \\n \\n \\n Stock-based compensation expense \\n \\n \\n Convertible Notes [Member] \\n \\n \\n Concentration Risk By Benchmark Axis \\n \\n \\n Statement Class Of Stock Axis \\n \\n \\n Customer 3 [Member] \\n \\n \\n Distro [Member] \\n \\n \\n \\n Accounts receivable \\n Accounts Receivable \\n \\n \\n \\n Security Deposit \\n Security deposit \\n \\n \\n Cash and cash equivalents \\n \\n \\n Sales Revenue [Member] \\n \\n \\n Stock payable \\n \\n \\n \\n Cost of revenue \\n Cost of revenue \\n \\n \\n Statement [Line Items] \\n \\n \\n \\n \\n Gross Profit \\n [Gross Profit] \\n Gross profit \\n \\n \\n Trade payable \\n \\n \\n Executives and senior management [Member] \\n \\n \\n Convertible shares \\n \\n \\n Series A Non - Voting Redeemable Preferred Stock [Member] \\n \\n \\n Series A Non-Voting Redeemable Preferred stock [Member] \\n \\n \\n \\n \\n Common stock, shares outstanding \\n Common stock, shares outstanding \\n Common stock, shares outstanding \\n \\n \\n Concentration Risk By Type Axis \\n \\n \\n Mr. Vapor [Member] \\n \\n \\n Customer Total [Member] \\n \\n \\n Capital Stock Payable [Member] \\n \\n \\n Series A Preferred Stock [Member] \\n \\n \\n \\n Inventory \\n Inventory \\n \\n \\n \\n Prepaid expenses \\n Prepaid expense \\n \\n \\n Accounts Receivable [Member] \\n \\n \\n Ordinary Common Stock [Member] \\n \\n \\n Brett H. Pojunis [Member] \\n \\n \\n Customer 2 [Member] \\n \\n \\n Statement [Table] \\n \\n \\n \\n Series C Preferred Stock [Member] \\n Series C Preferred Stock [Member] \\n \\n \\n Stock Payable Non Affiliates [Member] \\n \\n \\n Prepaid services \\n \\n \\n Employees [Member] \\n \\n \\n Derivative Instrument Risk Axis \\n \\n \\n Loon [Member] \\n \\n \\n Payroll liabilities \\n \\n \\n Prepayment for common shares issued to consultants \\n \\n \\n Short Term Debt Type Axis \\n \\n \\n Founder Series A Non Voting Redeemable Preferred Stock [Member] \\n \\n \\n \\n \\n Preferred Stock, shares issued \\n Preferred Stock, shares issued \\n Series A preferred stock, share issued \\n \\n \\n Nutriumph [Member] \\n \\n \\n \\n\\n\\t\\n \\n 0001673475 \\n \\n \\n 2024-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n \\n 2023-04-30 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n gpox:OrdinaryCommonStockMember \\n \\n \\n \\n 2024-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n gpox:OrdinaryCommonStockMember \\n \\n \\n \\n 2023-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n gpox:FoundersClassACommonStockShareMember \\n \\n \\n \\n 2024-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n gpox:BrettHPojunisMember \\n \\n \\n \\n 2020-05-05 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n gpox:FoundersClassACommonStockShareMember \\n \\n \\n \\n 2021-04-30 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n gpox:FoundersClassACommonStockShareMember \\n \\n \\n \\n 2023-04-30 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n gpox:CapitalStockPayableMember \\n \\n \\n \\n 2024-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n gpox:ExecutivesAndSeniorManagementMember \\n gpox:CapitalStockPayableMember \\n \\n \\n \\n 2024-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n gpox:StockPayableNonAffiliatesMember \\n \\n \\n \\n 2024-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n gpox:EmployeesMember \\n gpox:CapitalStockPayableMember \\n \\n \\n \\n 2024-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n \\n 2023-11-01 \\n 2024-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n \\n 2022-11-01 \\n 2023-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n \\n 2023-05-01 \\n 2024-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n \\n 2022-05-01 \\n 2023-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n gpox:ThreeCustomerConcentrationRiskMember \\n \\n \\n \\n 2023-05-01 \\n 2024-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n us-gaap:AccountsReceivableMember \\n gpox:OneCustomerConcentrationRiskMember \\n \\n \\n \\n 2023-05-01 \\n 2024-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n us-gaap:AccountsReceivableMember \\n gpox:TwoCustomerConcentrationRiskMember \\n \\n \\n \\n 2023-05-01 \\n 2024-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n us-gaap:AccountsReceivableMember \\n gpox:ThreeCustomerConcentrationRiskMember \\n \\n \\n \\n 2023-05-01 \\n 2024-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n gpox:TwoCustomerConcentrationRiskMember \\n \\n \\n \\n 2021-05-01 \\n 2022-04-30 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n us-gaap:AccountsReceivableMember \\n gpox:OneCustomerConcentrationRiskMember \\n \\n \\n \\n 2021-05-01 \\n 2022-04-30 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n us-gaap:AccountsReceivableMember \\n gpox:TwoCustomerConcentrationRiskMember \\n \\n \\n \\n 2021-05-01 \\n 2022-04-30 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n us-gaap:SalesRevenueNetMember \\n gpox:OneCustomerConcentrationRiskMember \\n \\n \\n \\n 2023-05-01 \\n 2024-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n us-gaap:SalesRevenueNetMember \\n gpox:TotalCustomerConcentrationRiskMember \\n \\n \\n \\n 2023-05-01 \\n 2024-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n us-gaap:SalesRevenueNetMember \\n gpox:OneCustomerConcentrationRiskMember \\n \\n \\n \\n 2022-05-01 \\n 2023-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n us-gaap:SalesRevenueNetMember \\n gpox:TotalCustomerConcentrationRiskMember \\n \\n \\n \\n 2022-05-01 \\n 2023-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n us-gaap:ProductMember \\n \\n \\n \\n 2023-05-01 \\n 2024-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n us-gaap:ProductMember \\n \\n \\n \\n 2022-05-01 \\n 2023-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n gpox:ShippingRecoveredMerchandiseSalesMember \\n \\n \\n \\n 2023-05-01 \\n 2024-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n gpox:ShippingRecoveredMerchandiseSalesMember \\n \\n \\n \\n 2022-05-01 \\n 2023-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n gpox:MrVaporMember \\n \\n \\n \\n 2024-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n gpox:NutriumphMember \\n \\n \\n \\n 2024-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n gpox:DistroMember \\n \\n \\n \\n 2024-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n gpox:LoonMember \\n \\n \\n \\n 2024-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n gpox:MrVaporMember \\n \\n \\n \\n 2023-04-30 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n gpox:NutriumphMember \\n \\n \\n \\n 2023-04-30 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n us-gaap:ConvertibleNotesPayableMember \\n \\n \\n \\n 2023-05-01 \\n 2024-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n us-gaap:ConvertibleNotesPayableMember \\n \\n \\n \\n 2021-05-01 \\n 2022-04-30 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n gpox:WarrantsMember \\n \\n \\n \\n 2024-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n gpox:WarrantsMember \\n \\n \\n \\n 2023-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n gpox:SeriesNonVotingRedeemablePreferredStockMember \\n \\n \\n \\n 2024-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n gpox:SeriesNonVotingRedeemablePreferredStockMember \\n \\n \\n \\n 2023-04-30 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n us-gaap:SeriesAPreferredStockMember \\n \\n \\n \\n 2023-04-30 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n us-gaap:SeriesAPreferredStockMember \\n \\n \\n \\n 2024-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n us-gaap:SeriesCPreferredStockMember \\n \\n \\n \\n 2023-04-30 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n us-gaap:SeriesCPreferredStockMember \\n \\n \\n \\n 2024-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n gpox:FounderSeriesANonVotingRedeemablePreferredStockMember \\n \\n \\n \\n 2024-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n gpox:FounderSeriesANonVotingRedeemablePreferredStockMember \\n \\n \\n \\n 2023-04-30 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n gpox:SeriesAPreferredStocksMember \\n \\n \\n \\n 2022-04-30 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n gpox:SeriesANonVotingRedeemablePreferredStockMember \\n \\n \\n \\n 2023-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n gpox:SeriesANonVotingRedeemablePreferredStockMember \\n \\n \\n \\n 2021-04-30 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n gpox:SeriesAPreferredStocksMember \\n \\n \\n \\n 2024-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n gpox:SeriesAPreferredStocksMember \\n \\n \\n \\n 2023-04-30 \\n \\n \\n\\t\\n iso4217:USD \\n \\n\\t\\n shares \\n \\n\\t\\n \\n \\n iso4217:USD \\n \\n \\n shares \\n \\n \\n \\n\\t\\n pure \\n \\n\\t1399842 \\n\\t517037 \\n\\t32470 \\n\\t43614 \\n\\t32470 \\n\\t43614 \\n\\t346003 \\n\\t0 \\n\\t39454300 \\n\\t44108860 \\n\\t115000 \\n\\t5000000 \\n\\t2440863 \\n\\t0 \\n\\t115000 \\n\\t115000 \\n\\t2440863 \\n\\t637083 \\n\\t1803780 \\n\\t916415 \\n\\t406662 \\n\\t55496 \\n\\t8844 \\n\\t69351 \\n\\t8844 \\n\\t69351 \\n\\t1361368 \\n\\t514337 \\n\\t Concentration Risk Type [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/SegmentReporting\\n Path: Concentration Risk Type [Axis] > Concentration Risk Type [Domain]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/FinancialServicesInsurance\\n Path: Ceded Credit Risk [Table] > Concentration Risk Type [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/FinancialServicesInsurance\\n Path: Concentration Risk Type [Axis] > Concentration Risk Type [Domain]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatements\\n Path: Nature of Operation, Product Information, Concentration of Risk [Table] > Concentration Risk Type [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatements\\n Path: Concentration Risk Type [Axis] > Concentration Risk Type [Domain]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthers\\n Path: Accounts and Financing Receivables [Table] > Concentration Risk Type [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthers\\n Path: Concentration Risk Type [Axis] > Concentration Risk Type [Domain]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/AccountingPolicies\\n Path: Nature of Operation, Product Information, Concentration of Risk [Table] > Concentration Risk Type [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/AccountingPolicies\\n Path: Concentration Risk Type [Axis] > Concentration Risk Type [Domain]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/RisksAndUncertainties\\n Path: Concentration Risk [Table] > Concentration Risk Type [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/RisksAndUncertainties\\n Path: Concentration Risk Type [Axis] > Concentration Risk Type [Domain]\\n PreferredLabel: None\\nProvenance: sheets include Presentation-like sheets\\n\\n\\n[Concept Relations]\\nID: us-gaap:ConcentrationRiskByTypeAxis\\n\\nDefinition (Dimensions/Domain/Hypercube):\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTable -> to=us-gaap:ConcentrationRiskByTypeAxis (role=http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthersScheduleOfAccountsNotesLoansAndFinancingReceivableTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthersScheduleOfAccountsNotesLoansAndFinancingReceivableTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthersScheduleOfAccountsNotesLoansAndFinancingReceivableTable)\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable -> to=us-gaap:ConcentrationRiskByTypeAxis (role=http://fasb.org/us-gaap/role/disclosure/SegmentReportingScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/SegmentReportingScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/SegmentReportingScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable)\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:ScheduleOfProductInformationTable -> to=us-gaap:ConcentrationRiskByTypeAxis (role=http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatementsScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatementsScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatementsScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:ScheduleOfProductInformationTable -> to=us-gaap:ConcentrationRiskByTypeAxis (role=http://fasb.org/us-gaap/role/disclosure/AccountingPoliciesScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/AccountingPoliciesScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/AccountingPoliciesScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:ConcentrationRiskTable -> to=us-gaap:ConcentrationRiskByTypeAxis (role=http://fasb.org/us-gaap/role/disclosure/RisksAndUncertaintiesConcentrationRiskTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/RisksAndUncertaintiesConcentrationRiskTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/RisksAndUncertaintiesConcentrationRiskTable)\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:CededCreditRiskTable -> to=us-gaap:ConcentrationRiskByTypeAxis (role=http://fasb.org/us-gaap/role/disclosure/FinancialServicesInsuranceCededCreditRiskTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/FinancialServicesInsuranceCededCreditRiskTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/FinancialServicesInsuranceCededCreditRiskTable)\\nProvenance: sheets include Definition-like sheets\\n\\n\\n[Concept Relations]\\nID: us-gaap:ConcentrationRiskByTypeAxis\\n\\nReferences:\\n- Taxonomy Implementation Guide | None | None\\nProvenance: sheets include Reference-like sheets\\n\\n\\n[Concept Relations]\\nID: us-gaap:ConcentrationRiskByBenchmarkAxis\\n\\nPresentation:\\n- Role: http://fasb.org/us-gaap/role/disclosure/SegmentReporting\\n Path: Schedule of Revenue by Major Customers, by Reporting Segments [Table] > Concentration Risk Benchmark [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/SegmentReporting\\n Path: Concentration Risk Benchmark [Axis] > Concentration Risk Benchmark [Domain]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/FinancialServicesInsurance\\n Path: Ceded Credit Risk [Table] > Concentration Risk Benchmark [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/FinancialServicesInsurance\\n Path: Concentration Risk Benchmark [Axis] > Concentration Risk Benchmark [Domain]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatements\\n Path: Nature of Operation, Product Information, Concentration of Risk [Table] > Concentration Risk Benchmark [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatements\\n Path: Concentration Risk Benchmark [Axis] > Concentration Risk Benchmark [Domain]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthers\\n Path: Accounts and Financing Receivables [Table] > Concentration Risk Benchmark [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthers\\n Path: Concentration Risk Benchmark [Axis] > Concentration Risk Benchmark [Domain]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/AccountingPolicies\\n Path: Nature of Operation, Product Information, Concentration of Risk [Table] > Concentration Risk Benchmark [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/AccountingPolicies\\n Path: Concentration Risk Benchmark [Axis] > Concentration Risk Benchmark [Domain]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/RisksAndUncertainties\\n Path: Concentration Risk [Table] > Concentration Risk Benchmark [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/RisksAndUncertainties\\n Path: Concentration Risk Benchmark [Axis] > Concentration Risk Benchmark [Domain]\\n PreferredLabel: None\\nProvenance: sheets include Presentation-like sheets\\n\\n\\n[Concept Relations]\\nID: us-gaap:ConcentrationRiskByBenchmarkAxis\\n\\nDefinition (Dimensions/Domain/Hypercube):\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTable -> to=us-gaap:ConcentrationRiskByBenchmarkAxis (role=http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthersScheduleOfAccountsNotesLoansAndFinancingReceivableTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthersScheduleOfAccountsNotesLoansAndFinancingReceivableTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthersScheduleOfAccountsNotesLoansAndFinancingReceivableTable)\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable -> to=us-gaap:ConcentrationRiskByBenchmarkAxis (role=http://fasb.org/us-gaap/role/disclosure/SegmentReportingScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/SegmentReportingScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/SegmentReportingScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable)\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:ScheduleOfProductInformationTable -> to=us-gaap:ConcentrationRiskByBenchmarkAxis (role=http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatementsScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatementsScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatementsScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:ScheduleOfProductInformationTable -> to=us-gaap:ConcentrationRiskByBenchmarkAxis (role=http://fasb.org/us-gaap/role/disclosure/AccountingPoliciesScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/AccountingPoliciesScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/AccountingPoliciesScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:ConcentrationRiskTable -> to=us-gaap:ConcentrationRiskByBenchmarkAxis (role=http://fasb.org/us-gaap/role/disclosure/RisksAndUncertaintiesConcentrationRiskTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/RisksAndUncertaintiesConcentrationRiskTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/RisksAndUncertaintiesConcentrationRiskTable)\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:CededCreditRiskTable -> to=us-gaap:ConcentrationRiskByBenchmarkAxis (role=http://fasb.org/us-gaap/role/disclosure/FinancialServicesInsuranceCededCreditRiskTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/FinancialServicesInsuranceCededCreditRiskTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/FinancialServicesInsuranceCededCreditRiskTable)\\nProvenance: sheets include Definition-like sheets\\n\\n\\n[Concept Relations]\\nID: us-gaap:ConcentrationRiskByBenchmarkAxis\\n\\nReferences:\\n- Taxonomy Implementation Guide | None | None\\nProvenance: sheets include Reference-like sheets\\n\\n\\n[Concept Relations]\\nID: us-gaap:AccountsReceivableMember\\n\\nPresentation:\\n- Role: http://fasb.org/us-gaap/role/disclosure/SegmentReporting\\n Path: Concentration Risk Benchmark [Domain] > Accounts Receivable [Member]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthers\\n Path: Concentration Risk Benchmark [Domain] > Accounts Receivable [Member]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/FinancialInstrumentsFairValueDisclosures\\n Path: Asset Class [Domain] > Accounts Receivable [Member]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/RisksAndUncertainties\\n Path: Concentration Risk Benchmark [Domain] > Accounts Receivable [Member]\\n PreferredLabel: None\\nProvenance: sheets include Presentation-like sheets\\n\\n\\n[Concept Relations]\\nID: us-gaap:AccountsReceivableMember\\n\\nDefinition (Dimensions/Domain/Hypercube):\\n- http://xbrl.org/int/dim/arcrole/domain-member: from=us-gaap:ConcentrationRiskBenchmarkDomain -> to=us-gaap:AccountsReceivableMember (role=http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthersScheduleOfAccountsNotesLoansAndFinancingReceivableTable)\\n- http://xbrl.org/int/dim/arcrole/domain-member: from=us-gaap:ConcentrationRiskBenchmarkDomain -> to=us-gaap:AccountsReceivableMember (role=http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthersScheduleOfAccountsNotesLoansAndFinancingReceivableTable)\\n- http://xbrl.org/int/dim/arcrole/domain-member: from=us-gaap:ConcentrationRiskBenchmarkDomain -> to=us-gaap:AccountsReceivableMember (role=http://fasb.org/us-gaap/role/disclosure/SegmentReportingScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable)\\n- http://xbrl.org/int/dim/arcrole/domain-member: from=us-gaap:ConcentrationRiskBenchmarkDomain -> to=us-gaap:AccountsReceivableMember (role=http://fasb.org/us-gaap/role/disclosure/SegmentReportingScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable)\\n- http://xbrl.org/int/dim/arcrole/domain-member: from=us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain -> to=us-gaap:AccountsReceivableMember (role=http://fasb.org/us-gaap/role/disclosure/FinancialInstrumentsFairValueDisclosuresFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable)\\n- http://xbrl.org/int/dim/arcrole/domain-member: from=us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain -> to=us-gaap:AccountsReceivableMember (role=http://fasb.org/us-gaap/role/disclosure/FinancialInstrumentsFairValueDisclosuresFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable)\\n- http://xbrl.org/int/dim/arcrole/domain-member: from=us-gaap:ConcentrationRiskBenchmarkDomain -> to=us-gaap:AccountsReceivableMember (role=http://fasb.org/us-gaap/role/disclosure/RisksAndUncertaintiesConcentrationRiskTable)\\n- http://xbrl.org/int/dim/arcrole/domain-member: from=us-gaap:ConcentrationRiskBenchmarkDomain -> to=us-gaap:AccountsReceivableMember (role=http://fasb.org/us-gaap/role/disclosure/RisksAndUncertaintiesConcentrationRiskTable)\\nProvenance: sheets include Definition-like sheets\\n\\nQuestion: Which axis-member pairs in the instance document report the concept \\\"ConcentrationRiskPercentage1\\\" with both \\\"ConcentrationRiskByTypeAxis\\\" and \\\"ConcentrationRiskByBenchmarkAxis\\\" but without any third axis, excluding cases where the member is \\\"LaborForceConcentrationRiskMember\\\" or \\\"UnionizedEmployeesConcentrationRiskMember\\\"?\\nAnswer:\\n\\n\""},"dqc_id":{"kind":"string","value":"\"DQC_US_0109\""},"answer":{"kind":"string","value":"\"['us-gaap:ConcentrationRiskByTypeAxis=gpox:ThreeCustomerConcentrationRiskMember', 'us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:AccountsReceivableMember']\""},"id":{"kind":"number","value":181,"string":"181"}}},{"rowIdx":182,"cells":{"query":{"kind":"string","value":"\"You are an auditor for XBRL filings. Given the question and the provided filing \\n(schema, presentation, calculation, definition, label, instance, and US GAAP taxonomy), \\nidentify erroneous US-GAAP concepts.\\n\\nYou must reference the US GAAP taxonomy to retrieve and check elements across the entire filing. \\nOutput only a JSON array of strings, each string is one erroneous concept.\\nOutput Example:\\n[\\\"us-gaap:Revenues\\\", \\\"us-gaap:OperatingIncomeLoss\\\"]\\n\\nNo explanations. No extra text. Only the JSON array.\\n\\n\\n##Schema document\\n\\n\\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n 000035 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) \\n link:presentationLink \\n link:calculationLink \\n link:definitionLink \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n Merchandise And Product Sales [Member] \\n \\n \\n Stock-based compensation expense \\n \\n \\n Convertible Notes [Member] \\n \\n \\n Concentration Risk By Benchmark Axis \\n \\n \\n Statement Class Of Stock Axis \\n \\n \\n Customer 3 [Member] \\n \\n \\n Distro [Member] \\n \\n \\n \\n Accounts receivable \\n Accounts Receivable \\n \\n \\n \\n Security Deposit \\n Security deposit \\n \\n \\n Cash and cash equivalents \\n \\n \\n Sales Revenue [Member] \\n \\n \\n Stock payable \\n \\n \\n \\n Cost of revenue \\n Cost of revenue \\n \\n \\n Statement [Line Items] \\n \\n \\n \\n \\n Gross Profit \\n [Gross Profit] \\n Gross profit \\n \\n \\n Trade payable \\n \\n \\n Executives and senior management [Member] \\n \\n \\n Convertible shares \\n \\n \\n Series A Non - Voting Redeemable Preferred Stock [Member] \\n \\n \\n Series A Non-Voting Redeemable Preferred stock [Member] \\n \\n \\n \\n \\n Common stock, shares outstanding \\n Common stock, shares outstanding \\n Common stock, shares outstanding \\n \\n \\n Concentration Risk By Type Axis \\n \\n \\n Mr. Vapor [Member] \\n \\n \\n Customer Total [Member] \\n \\n \\n Capital Stock Payable [Member] \\n \\n \\n Series A Preferred Stock [Member] \\n \\n \\n \\n Inventory \\n Inventory \\n \\n \\n \\n Prepaid expenses \\n Prepaid expense \\n \\n \\n Accounts Receivable [Member] \\n \\n \\n Ordinary Common Stock [Member] \\n \\n \\n Brett H. Pojunis [Member] \\n \\n \\n Customer 2 [Member] \\n \\n \\n Statement [Table] \\n \\n \\n \\n Series C Preferred Stock [Member] \\n Series C Preferred Stock [Member] \\n \\n \\n Stock Payable Non Affiliates [Member] \\n \\n \\n Prepaid services \\n \\n \\n Employees [Member] \\n \\n \\n Derivative Instrument Risk Axis \\n \\n \\n Loon [Member] \\n \\n \\n Payroll liabilities \\n \\n \\n Prepayment for common shares issued to consultants \\n \\n \\n Short Term Debt Type Axis \\n \\n \\n Founder Series A Non Voting Redeemable Preferred Stock [Member] \\n \\n \\n \\n \\n Preferred Stock, shares issued \\n Preferred Stock, shares issued \\n Series A preferred stock, share issued \\n \\n \\n Nutriumph [Member] \\n \\n \\n \\n\\n\\t\\n \\n 0001673475 \\n \\n \\n 2024-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n \\n 2023-04-30 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n gpox:OrdinaryCommonStockMember \\n \\n \\n \\n 2024-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n gpox:OrdinaryCommonStockMember \\n \\n \\n \\n 2023-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n gpox:FoundersClassACommonStockShareMember \\n \\n \\n \\n 2024-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n gpox:BrettHPojunisMember \\n \\n \\n \\n 2020-05-05 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n gpox:FoundersClassACommonStockShareMember \\n \\n \\n \\n 2021-04-30 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n gpox:FoundersClassACommonStockShareMember \\n \\n \\n \\n 2023-04-30 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n gpox:CapitalStockPayableMember \\n \\n \\n \\n 2024-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n gpox:ExecutivesAndSeniorManagementMember \\n gpox:CapitalStockPayableMember \\n \\n \\n \\n 2024-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n gpox:StockPayableNonAffiliatesMember \\n \\n \\n \\n 2024-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n gpox:EmployeesMember \\n gpox:CapitalStockPayableMember \\n \\n \\n \\n 2024-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n \\n 2023-11-01 \\n 2024-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n \\n 2022-11-01 \\n 2023-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n \\n 2023-05-01 \\n 2024-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n \\n 2022-05-01 \\n 2023-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n gpox:ThreeCustomerConcentrationRiskMember \\n \\n \\n \\n 2023-05-01 \\n 2024-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n us-gaap:AccountsReceivableMember \\n gpox:OneCustomerConcentrationRiskMember \\n \\n \\n \\n 2023-05-01 \\n 2024-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n us-gaap:AccountsReceivableMember \\n gpox:TwoCustomerConcentrationRiskMember \\n \\n \\n \\n 2023-05-01 \\n 2024-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n us-gaap:AccountsReceivableMember \\n gpox:ThreeCustomerConcentrationRiskMember \\n \\n \\n \\n 2023-05-01 \\n 2024-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n gpox:TwoCustomerConcentrationRiskMember \\n \\n \\n \\n 2021-05-01 \\n 2022-04-30 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n us-gaap:AccountsReceivableMember \\n gpox:OneCustomerConcentrationRiskMember \\n \\n \\n \\n 2021-05-01 \\n 2022-04-30 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n us-gaap:AccountsReceivableMember \\n gpox:TwoCustomerConcentrationRiskMember \\n \\n \\n \\n 2021-05-01 \\n 2022-04-30 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n us-gaap:SalesRevenueNetMember \\n gpox:OneCustomerConcentrationRiskMember \\n \\n \\n \\n 2023-05-01 \\n 2024-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n us-gaap:SalesRevenueNetMember \\n gpox:TotalCustomerConcentrationRiskMember \\n \\n \\n \\n 2023-05-01 \\n 2024-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n us-gaap:SalesRevenueNetMember \\n gpox:OneCustomerConcentrationRiskMember \\n \\n \\n \\n 2022-05-01 \\n 2023-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n us-gaap:SalesRevenueNetMember \\n gpox:TotalCustomerConcentrationRiskMember \\n \\n \\n \\n 2022-05-01 \\n 2023-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n us-gaap:ProductMember \\n \\n \\n \\n 2023-05-01 \\n 2024-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n us-gaap:ProductMember \\n \\n \\n \\n 2022-05-01 \\n 2023-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n gpox:ShippingRecoveredMerchandiseSalesMember \\n \\n \\n \\n 2023-05-01 \\n 2024-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n gpox:ShippingRecoveredMerchandiseSalesMember \\n \\n \\n \\n 2022-05-01 \\n 2023-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n gpox:MrVaporMember \\n \\n \\n \\n 2024-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n gpox:NutriumphMember \\n \\n \\n \\n 2024-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n gpox:DistroMember \\n \\n \\n \\n 2024-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n gpox:LoonMember \\n \\n \\n \\n 2024-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n gpox:MrVaporMember \\n \\n \\n \\n 2023-04-30 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n gpox:NutriumphMember \\n \\n \\n \\n 2023-04-30 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n us-gaap:ConvertibleNotesPayableMember \\n \\n \\n \\n 2023-05-01 \\n 2024-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n us-gaap:ConvertibleNotesPayableMember \\n \\n \\n \\n 2021-05-01 \\n 2022-04-30 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n gpox:WarrantsMember \\n \\n \\n \\n 2024-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n gpox:WarrantsMember \\n \\n \\n \\n 2023-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n gpox:SeriesNonVotingRedeemablePreferredStockMember \\n \\n \\n \\n 2024-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n gpox:SeriesNonVotingRedeemablePreferredStockMember \\n \\n \\n \\n 2023-04-30 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n us-gaap:SeriesAPreferredStockMember \\n \\n \\n \\n 2023-04-30 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n us-gaap:SeriesAPreferredStockMember \\n \\n \\n \\n 2024-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n us-gaap:SeriesCPreferredStockMember \\n \\n \\n \\n 2023-04-30 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n us-gaap:SeriesCPreferredStockMember \\n \\n \\n \\n 2024-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n gpox:FounderSeriesANonVotingRedeemablePreferredStockMember \\n \\n \\n \\n 2024-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n gpox:FounderSeriesANonVotingRedeemablePreferredStockMember \\n \\n \\n \\n 2023-04-30 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n gpox:SeriesAPreferredStocksMember \\n \\n \\n \\n 2022-04-30 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n gpox:SeriesANonVotingRedeemablePreferredStockMember \\n \\n \\n \\n 2023-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n gpox:SeriesANonVotingRedeemablePreferredStockMember \\n \\n \\n \\n 2021-04-30 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n gpox:SeriesAPreferredStocksMember \\n \\n \\n \\n 2024-01-31 \\n \\n \\n\\t\\n \\n 0001673475 \\n \\n gpox:SeriesAPreferredStocksMember \\n \\n \\n \\n 2023-04-30 \\n \\n \\n\\t\\n iso4217:USD \\n \\n\\t\\n shares \\n \\n\\t\\n \\n \\n iso4217:USD \\n \\n \\n shares \\n \\n \\n \\n\\t\\n pure \\n \\n\\t1399842 \\n\\t517037 \\n\\t32470 \\n\\t43614 \\n\\t32470 \\n\\t43614 \\n\\t346003 \\n\\t0 \\n\\t39454300 \\n\\t44108860 \\n\\t115000 \\n\\t5000000 \\n\\t2440863 \\n\\t0 \\n\\t115000 \\n\\t115000 \\n\\t2440863 \\n\\t637083 \\n\\t1803780 \\n\\t916415 \\n\\t406662 \\n\\t55496 \\n\\t8844 \\n\\t69351 \\n\\t8844 \\n\\t69351 \\n\\t1361368 \\n\\t514337 \\n\\t Concentration Risk Benchmark [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/SegmentReporting\\n Path: Concentration Risk Benchmark [Axis] > Concentration Risk Benchmark [Domain]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/FinancialServicesInsurance\\n Path: Ceded Credit Risk [Table] > Concentration Risk Benchmark [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/FinancialServicesInsurance\\n Path: Concentration Risk Benchmark [Axis] > Concentration Risk Benchmark [Domain]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatements\\n Path: Nature of Operation, Product Information, Concentration of Risk [Table] > Concentration Risk Benchmark [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatements\\n Path: Concentration Risk Benchmark [Axis] > Concentration Risk Benchmark [Domain]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthers\\n Path: Accounts and Financing Receivables [Table] > Concentration Risk Benchmark [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthers\\n Path: Concentration Risk Benchmark [Axis] > Concentration Risk Benchmark [Domain]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/AccountingPolicies\\n Path: Nature of Operation, Product Information, Concentration of Risk [Table] > Concentration Risk Benchmark [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/AccountingPolicies\\n Path: Concentration Risk Benchmark [Axis] > Concentration Risk Benchmark [Domain]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/RisksAndUncertainties\\n Path: Concentration Risk [Table] > Concentration Risk Benchmark [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/RisksAndUncertainties\\n Path: Concentration Risk Benchmark [Axis] > Concentration Risk Benchmark [Domain]\\n PreferredLabel: None\\nProvenance: sheets include Presentation-like sheets\\n\\n\\n[Concept Relations]\\nID: us-gaap:ConcentrationRiskByBenchmarkAxis\\n\\nDefinition (Dimensions/Domain/Hypercube):\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTable -> to=us-gaap:ConcentrationRiskByBenchmarkAxis (role=http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthersScheduleOfAccountsNotesLoansAndFinancingReceivableTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthersScheduleOfAccountsNotesLoansAndFinancingReceivableTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthersScheduleOfAccountsNotesLoansAndFinancingReceivableTable)\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable -> to=us-gaap:ConcentrationRiskByBenchmarkAxis (role=http://fasb.org/us-gaap/role/disclosure/SegmentReportingScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/SegmentReportingScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/SegmentReportingScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable)\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:ScheduleOfProductInformationTable -> to=us-gaap:ConcentrationRiskByBenchmarkAxis (role=http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatementsScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatementsScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatementsScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:ScheduleOfProductInformationTable -> to=us-gaap:ConcentrationRiskByBenchmarkAxis (role=http://fasb.org/us-gaap/role/disclosure/AccountingPoliciesScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/AccountingPoliciesScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/AccountingPoliciesScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:ConcentrationRiskTable -> to=us-gaap:ConcentrationRiskByBenchmarkAxis (role=http://fasb.org/us-gaap/role/disclosure/RisksAndUncertaintiesConcentrationRiskTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/RisksAndUncertaintiesConcentrationRiskTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/RisksAndUncertaintiesConcentrationRiskTable)\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:CededCreditRiskTable -> to=us-gaap:ConcentrationRiskByBenchmarkAxis (role=http://fasb.org/us-gaap/role/disclosure/FinancialServicesInsuranceCededCreditRiskTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/FinancialServicesInsuranceCededCreditRiskTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByBenchmarkAxis -> to=us-gaap:ConcentrationRiskBenchmarkDomain (role=http://fasb.org/us-gaap/role/disclosure/FinancialServicesInsuranceCededCreditRiskTable)\\nProvenance: sheets include Definition-like sheets\\n\\n\\n[Concept Relations]\\nID: us-gaap:ConcentrationRiskByBenchmarkAxis\\n\\nReferences:\\n- Taxonomy Implementation Guide | None | None\\nProvenance: sheets include Reference-like sheets\\n\\n\\n[Concept Relations]\\nID: us-gaap:AccountsReceivableMember\\n\\nPresentation:\\n- Role: http://fasb.org/us-gaap/role/disclosure/SegmentReporting\\n Path: Concentration Risk Benchmark [Domain] > Accounts Receivable [Member]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthers\\n Path: Concentration Risk Benchmark [Domain] > Accounts Receivable [Member]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/FinancialInstrumentsFairValueDisclosures\\n Path: Asset Class [Domain] > Accounts Receivable [Member]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/RisksAndUncertainties\\n Path: Concentration Risk Benchmark [Domain] > Accounts Receivable [Member]\\n PreferredLabel: None\\nProvenance: sheets include Presentation-like sheets\\n\\n\\n[Concept Relations]\\nID: us-gaap:AccountsReceivableMember\\n\\nDefinition (Dimensions/Domain/Hypercube):\\n- http://xbrl.org/int/dim/arcrole/domain-member: from=us-gaap:ConcentrationRiskBenchmarkDomain -> to=us-gaap:AccountsReceivableMember (role=http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthersScheduleOfAccountsNotesLoansAndFinancingReceivableTable)\\n- http://xbrl.org/int/dim/arcrole/domain-member: from=us-gaap:ConcentrationRiskBenchmarkDomain -> to=us-gaap:AccountsReceivableMember (role=http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthersScheduleOfAccountsNotesLoansAndFinancingReceivableTable)\\n- http://xbrl.org/int/dim/arcrole/domain-member: from=us-gaap:ConcentrationRiskBenchmarkDomain -> to=us-gaap:AccountsReceivableMember (role=http://fasb.org/us-gaap/role/disclosure/SegmentReportingScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable)\\n- http://xbrl.org/int/dim/arcrole/domain-member: from=us-gaap:ConcentrationRiskBenchmarkDomain -> to=us-gaap:AccountsReceivableMember (role=http://fasb.org/us-gaap/role/disclosure/SegmentReportingScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable)\\n- http://xbrl.org/int/dim/arcrole/domain-member: from=us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain -> to=us-gaap:AccountsReceivableMember (role=http://fasb.org/us-gaap/role/disclosure/FinancialInstrumentsFairValueDisclosuresFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable)\\n- http://xbrl.org/int/dim/arcrole/domain-member: from=us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain -> to=us-gaap:AccountsReceivableMember (role=http://fasb.org/us-gaap/role/disclosure/FinancialInstrumentsFairValueDisclosuresFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable)\\n- http://xbrl.org/int/dim/arcrole/domain-member: from=us-gaap:ConcentrationRiskBenchmarkDomain -> to=us-gaap:AccountsReceivableMember (role=http://fasb.org/us-gaap/role/disclosure/RisksAndUncertaintiesConcentrationRiskTable)\\n- http://xbrl.org/int/dim/arcrole/domain-member: from=us-gaap:ConcentrationRiskBenchmarkDomain -> to=us-gaap:AccountsReceivableMember (role=http://fasb.org/us-gaap/role/disclosure/RisksAndUncertaintiesConcentrationRiskTable)\\nProvenance: sheets include Definition-like sheets\\n\\n\\n[Concept Relations]\\nID: us-gaap:ConcentrationRiskByTypeAxis\\n\\nPresentation:\\n- Role: http://fasb.org/us-gaap/role/disclosure/SegmentReporting\\n Path: Schedule of Revenue by Major Customers, by Reporting Segments [Table] > Concentration Risk Type [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/SegmentReporting\\n Path: Concentration Risk Type [Axis] > Concentration Risk Type [Domain]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/FinancialServicesInsurance\\n Path: Ceded Credit Risk [Table] > Concentration Risk Type [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/FinancialServicesInsurance\\n Path: Concentration Risk Type [Axis] > Concentration Risk Type [Domain]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatements\\n Path: Nature of Operation, Product Information, Concentration of Risk [Table] > Concentration Risk Type [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatements\\n Path: Concentration Risk Type [Axis] > Concentration Risk Type [Domain]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthers\\n Path: Accounts and Financing Receivables [Table] > Concentration Risk Type [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthers\\n Path: Concentration Risk Type [Axis] > Concentration Risk Type [Domain]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/AccountingPolicies\\n Path: Nature of Operation, Product Information, Concentration of Risk [Table] > Concentration Risk Type [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/AccountingPolicies\\n Path: Concentration Risk Type [Axis] > Concentration Risk Type [Domain]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/RisksAndUncertainties\\n Path: Concentration Risk [Table] > Concentration Risk Type [Axis]\\n PreferredLabel: None\\n- Role: http://fasb.org/us-gaap/role/disclosure/RisksAndUncertainties\\n Path: Concentration Risk Type [Axis] > Concentration Risk Type [Domain]\\n PreferredLabel: None\\nProvenance: sheets include Presentation-like sheets\\n\\n\\n[Concept Relations]\\nID: us-gaap:ConcentrationRiskByTypeAxis\\n\\nDefinition (Dimensions/Domain/Hypercube):\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTable -> to=us-gaap:ConcentrationRiskByTypeAxis (role=http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthersScheduleOfAccountsNotesLoansAndFinancingReceivableTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthersScheduleOfAccountsNotesLoansAndFinancingReceivableTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/ReceivablesLoansNotesReceivableAndOthersScheduleOfAccountsNotesLoansAndFinancingReceivableTable)\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable -> to=us-gaap:ConcentrationRiskByTypeAxis (role=http://fasb.org/us-gaap/role/disclosure/SegmentReportingScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/SegmentReportingScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/SegmentReportingScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable)\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:ScheduleOfProductInformationTable -> to=us-gaap:ConcentrationRiskByTypeAxis (role=http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatementsScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatementsScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/OrganizationConsolidationAndPresentationOfFinancialStatementsScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:ScheduleOfProductInformationTable -> to=us-gaap:ConcentrationRiskByTypeAxis (role=http://fasb.org/us-gaap/role/disclosure/AccountingPoliciesScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/AccountingPoliciesScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/AccountingPoliciesScheduleOfProductInformationTable)\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:ConcentrationRiskTable -> to=us-gaap:ConcentrationRiskByTypeAxis (role=http://fasb.org/us-gaap/role/disclosure/RisksAndUncertaintiesConcentrationRiskTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/RisksAndUncertaintiesConcentrationRiskTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/RisksAndUncertaintiesConcentrationRiskTable)\\n- http://xbrl.org/int/dim/arcrole/hypercube-dimension: from=us-gaap:CededCreditRiskTable -> to=us-gaap:ConcentrationRiskByTypeAxis (role=http://fasb.org/us-gaap/role/disclosure/FinancialServicesInsuranceCededCreditRiskTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-domain: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/FinancialServicesInsuranceCededCreditRiskTable)\\n- http://xbrl.org/int/dim/arcrole/dimension-default: from=us-gaap:ConcentrationRiskByTypeAxis -> to=us-gaap:ConcentrationRiskTypeDomain (role=http://fasb.org/us-gaap/role/disclosure/FinancialServicesInsuranceCededCreditRiskTable)\\nProvenance: sheets include Definition-like sheets\\n\\n\\n[Concept Relations]\\nID: us-gaap:ConcentrationRiskByTypeAxis\\n\\nReferences:\\n- Taxonomy Implementation Guide | None | None\\nProvenance: sheets include Reference-like sheets\\n\\nQuestion: Which axis-member pairs in the instance document report the concept \\\"ConcentrationRiskPercentage1\\\" with both \\\"ConcentrationRiskByTypeAxis\\\" and \\\"ConcentrationRiskByBenchmarkAxis\\\" but without any third axis, excluding cases where the member is \\\"LaborForceConcentrationRiskMember\\\" or \\\"UnionizedEmployeesConcentrationRiskMember\\\"?\\nAnswer:\\n\\n\""},"dqc_id":{"kind":"string","value":"\"DQC_US_0109\""},"answer":{"kind":"string","value":"\"['us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:AccountsReceivableMember', 'us-gaap:ConcentrationRiskByTypeAxis=gpox:OneCustomerConcentrationRiskMember']\""},"id":{"kind":"number","value":182,"string":"182"}}},{"rowIdx":183,"cells":{"query":{"kind":"string","value":"\"You are an auditor for XBRL filings. Given the question and the provided filing \\n(schema, presentation, calculation, definition, label, instance, and US GAAP taxonomy), \\nidentify erroneous US-GAAP concepts.\\n\\nYou must reference the US GAAP taxonomy to retrieve and check elements across the entire filing. \\nOutput only a JSON array of strings, each string is one erroneous concept.\\nOutput Example:\\n[\\\"us-gaap:Revenues\\\", \\\"us-gaap:OperatingIncomeLoss\\\"]\\n\\nNo explanations. No extra text. Only the JSON array.\\n\\n\\n##Schema document\\n\\n\\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n